Wealth Effects’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Wealth Effects's PFE Position: Q2 2026 in Review
Wealth Effects increased its Pfizer (PFE) stake by 2.6% in Q2 2026, buying an estimated $52.5K and bringing the position to 78,083 shares worth $1.88M. The position accounts for 0.51% of the portfolio, ranked #41.
Wealth Effects first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.1M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Wealth Effects held 78,083 shares of Pfizer worth $1.88M as of Q2 2026.
- Wealth Effects bought 2,008 Pfizer shares in Q2 2026, an estimated $52.5K.
- Pfizer made up 0.51% of Wealth Effects's portfolio in Q2 2026, its #41 holding.
- Wealth Effects first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Wealth Effects's Pfizer position peaked at $4.1M in Q4 2021.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Wealth Effects's 13F filing for Q2 2026, filed 6 Aug 2026.